SHL Expands Range of Automation Solutions for Auto Injector Assembly
Using the latest technology and software available, SHL Automation has developed a sub-assembly equipment that is robust, efficient and addresses various common bottlenecks of automated systems.
Taoyuan, Taiwan, February 12, 2011 --(PR.com)-- With an increasing number of drug delivery devices, primarily auto injectors and pen injectors, under development and soon entering mass production, SHL Automation has been steadily working towards enhancing SHL’s in-house automated sub-assembly solutions. One related development program involves the re-engineering and streamlining of component assembly for a key auto injector project.
The goals for the program were to improve cycle time, provide 100% visual inspection, and to ultimately overcome the bottleneck to any automated system – ‘down time’. Utilizing some of the latest technology and software available, SHL Automation began working with related Project Management teams to develop a unique hybrid automation system that addresses these goals. The system is built around a customized linear assembly line with semi- and fully-automatic modules. These modules can be adjusted or modified all the way up to a 100% fully automatic line with bowl feeders, automatic tray loading stackers and pick and place robots depending on the volume needs of the assembled auto injector. Also incorporated within the project set-up are cosmetic vision controls that ensure customer specifications are adequately met. Process Qualification (PQ) can also be conducted for the separate modules in order to cut down on assembly validation time.
SHL General Manager Frank Isaksson commented on recent progress stating, “When producing millions of auto injectors per year for customers, ensuring that we have a robust assemble process is paramount. The linear assembly line system is a step in the right direction and is a testament to the innovative approach of SHL Automation. Continuous improvement is a key factor in all aspects of our operations here at SHL.”
Creating a robust system and enhancing efficiencies has been achieved with the development of this next generation sub-assembly equipment. This, along with other innovations, will continue to be introduced by SHL utilizing the in-house resources that we have invested in over the past decade. SHL Automation currently has over 100 experienced staff and engineers working with our customers and partners to meet the challenge of the growing number of devices, more complex components, significantly higher component volumes and variable forecasts.
About SHL
SHL is the world’s largest privately-owned designer, developer and manufacturer of advanced drug delivery devices. We have over 1,500 staff globally (1000 staff in Taiwan), with our primary design centers located in the USA and Sweden and manufacturing centers located in Asia.
SHL supplies auto injectors, pen injectors and inhaler systems to global pharmaceutical and biotech companies. Significant investment in R&D has enhanced our broad pipeline of “next generation” drug delivery systems. These innovative devices include a range of disposable and reusable injectors with fixed or variable dosing, enhanced precision and the ability to accommodate high viscosities.
Our organization consists of three distinct group companies:
SHL Medical
Designs, develops and manufactures advanced drug delivery devices for leading pharmaceutical and biotech companies
SHL Healthcare
Develops and manufactures equipment solutions for home, hospital and long term care use
SHL Technologies
Provides contract manufacturing and engineering services for the production of complex medtech and industrial products
For additional information visit www.shl-group.com or contact us at info@shl-group.com
SHL Media Contact:
Steven R. Kaufman
Marketing Director
+886 932 111 460
pr@shl-group.com
###
The goals for the program were to improve cycle time, provide 100% visual inspection, and to ultimately overcome the bottleneck to any automated system – ‘down time’. Utilizing some of the latest technology and software available, SHL Automation began working with related Project Management teams to develop a unique hybrid automation system that addresses these goals. The system is built around a customized linear assembly line with semi- and fully-automatic modules. These modules can be adjusted or modified all the way up to a 100% fully automatic line with bowl feeders, automatic tray loading stackers and pick and place robots depending on the volume needs of the assembled auto injector. Also incorporated within the project set-up are cosmetic vision controls that ensure customer specifications are adequately met. Process Qualification (PQ) can also be conducted for the separate modules in order to cut down on assembly validation time.
SHL General Manager Frank Isaksson commented on recent progress stating, “When producing millions of auto injectors per year for customers, ensuring that we have a robust assemble process is paramount. The linear assembly line system is a step in the right direction and is a testament to the innovative approach of SHL Automation. Continuous improvement is a key factor in all aspects of our operations here at SHL.”
Creating a robust system and enhancing efficiencies has been achieved with the development of this next generation sub-assembly equipment. This, along with other innovations, will continue to be introduced by SHL utilizing the in-house resources that we have invested in over the past decade. SHL Automation currently has over 100 experienced staff and engineers working with our customers and partners to meet the challenge of the growing number of devices, more complex components, significantly higher component volumes and variable forecasts.
About SHL
SHL is the world’s largest privately-owned designer, developer and manufacturer of advanced drug delivery devices. We have over 1,500 staff globally (1000 staff in Taiwan), with our primary design centers located in the USA and Sweden and manufacturing centers located in Asia.
SHL supplies auto injectors, pen injectors and inhaler systems to global pharmaceutical and biotech companies. Significant investment in R&D has enhanced our broad pipeline of “next generation” drug delivery systems. These innovative devices include a range of disposable and reusable injectors with fixed or variable dosing, enhanced precision and the ability to accommodate high viscosities.
Our organization consists of three distinct group companies:
SHL Medical
Designs, develops and manufactures advanced drug delivery devices for leading pharmaceutical and biotech companies
SHL Healthcare
Develops and manufactures equipment solutions for home, hospital and long term care use
SHL Technologies
Provides contract manufacturing and engineering services for the production of complex medtech and industrial products
For additional information visit www.shl-group.com or contact us at info@shl-group.com
SHL Media Contact:
Steven R. Kaufman
Marketing Director
+886 932 111 460
pr@shl-group.com
###
Contact
SHL Group (Scandinavian Health Group Ltd)
Steven Kaufman
+886-3-2170303
www.shl-group.com
Steven Kaufman
+886-3-2170303
www.shl-group.com
Contact
Categories